| Primary |
| Abortion Induced |
77.2% |
| Termination Of Pregnancy |
20.5% |
| Abortion |
0.9% |
| Cushing's Syndrome |
0.6% |
| Analgesic Therapy |
0.3% |
| Antibiotic Therapy |
0.3% |
| Respiratory Failure |
0.3% |
|
| Haemorrhage |
29.8% |
| Abortion Incomplete |
21.9% |
| Pregnancy |
11.6% |
| Vomiting |
6.3% |
| Pain |
5.6% |
| Muscle Spasms |
5.0% |
| Pyrexia |
3.4% |
| Menorrhagia |
2.8% |
| Syncope |
2.2% |
| Anaemia |
1.6% |
| Nausea |
1.6% |
| Hypersensitivity |
1.3% |
| Abdominal Pain |
0.9% |
| Ectopic Pregnancy |
0.9% |
| Maternal Exposure Timing Unspecified |
0.9% |
| Pelvic Pain |
0.9% |
| Tachycardia |
0.9% |
| Unevaluable Event |
0.9% |
| Dehydration |
0.6% |
| Headache |
0.6% |
|
| Secondary |
| Abortion Induced |
20.3% |
| Drug Use For Unknown Indication |
20.3% |
| Abortion |
18.8% |
| Induced Labour |
8.7% |
| Premature Labour |
8.7% |
| Vomiting |
8.7% |
| Hypertension |
4.3% |
| Gestational Diabetes |
1.4% |
| Limb Discomfort |
1.4% |
| Off Label Use |
1.4% |
| Oral Contraception |
1.4% |
| Pain |
1.4% |
| Psoriasis |
1.4% |
| Rosacea |
1.4% |
|
| Intra-uterine Death |
10.3% |
| Off Label Use |
10.3% |
| Uterine Rupture |
10.3% |
| White Blood Cell Count Increased |
10.3% |
| Vasculitis Cerebral |
6.9% |
| Arteriospasm Coronary |
3.4% |
| Craniosynostosis |
3.4% |
| Drug Exposure Before Pregnancy |
3.4% |
| Drug Exposure During Pregnancy |
3.4% |
| Drug Ineffective For Unapproved Indication |
3.4% |
| Induced Abortion Failed |
3.4% |
| No Adverse Reaction |
3.4% |
| Oligohydramnios |
3.4% |
| Pregnancy |
3.4% |
| Premature Baby |
3.4% |
| Pyelonephritis |
3.4% |
| Rash |
3.4% |
| Sepsis |
3.4% |
| Uterine Haemorrhage |
3.4% |
| Vomiting |
3.4% |
|
| Concomitant |
| Abortion Induced |
24.0% |
| Cytomegalovirus Infection |
12.0% |
| Anaesthesia |
10.0% |
| Analgesic Therapy |
10.0% |
| Ewing's Sarcoma |
8.0% |
| Abortion |
4.0% |
| Chronic Myeloid Leukaemia |
4.0% |
| Induced Labour |
4.0% |
| Labour Induction |
4.0% |
| Premature Labour |
4.0% |
| Antibiotic Prophylaxis |
2.0% |
| Cerebral Haemorrhage |
2.0% |
| Contraception |
2.0% |
| Intra-uterine Death |
2.0% |
| Nosocomial Infection |
2.0% |
| Premenstrual Syndrome |
2.0% |
| Prophylaxis |
2.0% |
| Vomiting |
2.0% |
|
| Drug Exposure During Pregnancy |
14.8% |
| Off Label Use |
14.8% |
| Ultrasound Antenatal Screen Abnormal |
7.4% |
| Circulatory Collapse |
3.7% |
| Electrocardiogram Qt Prolonged |
3.7% |
| Foetal Disorder |
3.7% |
| Hyperventilation |
3.7% |
| No Adverse Reaction |
3.7% |
| Oligohydramnios |
3.7% |
| Placental Infarction |
3.7% |
| Pulmonary Embolism |
3.7% |
| Rash Generalised |
3.7% |
| Syncope |
3.7% |
| Tachycardia |
3.7% |
| Therapeutic Response Delayed |
3.7% |
| Troponin Increased |
3.7% |
| Type Iv Hypersensitivity Reaction |
3.7% |
| Ultrasound Scan Abnormal |
3.7% |
| Unresponsive To Stimuli |
3.7% |
| Urinary Incontinence |
3.7% |
|
| Interacting |
| Abortion Induced |
42.9% |
| Analgesic Therapy |
28.6% |
| Antibiotic Therapy |
14.3% |
| Respiratory Failure |
14.3% |
|
| Respiratory Failure |
50.0% |
| Superinfection |
50.0% |
|
